Self-targeted knockdown of CD44 improves cisplatin sensitivity of chemoresistant non-small cell lung cancer cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Quan, Yu Hua | - |
dc.contributor.author | Lim, Ji-Young | - |
dc.contributor.author | Choi, Byeong Hyeon | - |
dc.contributor.author | Choi, Yeonho | - |
dc.contributor.author | Choi, Young Ho | - |
dc.contributor.author | Park, Ji-Ho | - |
dc.contributor.author | Kim, Hyun Koo | - |
dc.date.accessioned | 2021-09-01T18:07:26Z | - |
dc.date.available | 2021-09-01T18:07:26Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2019-03 | - |
dc.identifier.issn | 0344-5704 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/67138 | - |
dc.description.abstract | BackgroundChemoresistance remains a major challenge for effective chemotherapy of non-small-cell lung carcinoma (NSCLC). CD44 expression is related to the susceptibility of various cancer cell types to anticancer drugs. Here, we systematically investigated the CD44-dependent chemoresistance of NSCLC cells and developed a liposomal siRNA delivery system to overcome this chemoresistance by the self-targeted downregulation of CD44.MethodsWe confirmed the relationship between the expression of CD44 and the chemosensitivity of NSCLC cells using flow cytometry and MTT assay. We then generated and characterized cisplatin-resistant cell lines and compared the expression of CD44 in resistant cells to that in parental cells using western blotting. To evaluate whether the chemosensitivity of resistant cells depends on CD44 expression, we performed CD44 knockdown using CD44 siRNA and detected the chemosensitivity of these cells. Additionally, we prepared hyaluronic acid (HA)-coated liposomes as a targeted delivery system to selectively deliver CD44-specific siRNA to chemoresistant NSCLC cells and observed whether the chemosensitivity of these cells was improved.ResultsWe found that CD44 expression is inversely proportional to the degree of cellular response to cisplatin chemotherapy and that CD44 is overexpressed in chemoresistant NSCLC cells. By performing CD44 knockdown using siRNA, we reconfirmed that the chemosensitivity of resistant cells depends on CD44 expression. We also observed that HA-liposome-mediated siRNA delivery prior to cisplatin chemotherapy significantly reduced CD44 expression and enhanced cisplatin sensitivity in chemoresistant NSCLC cells.ConclusionsThese results suggest that self-targeted downregulation of chemoresistance-associated cell surface proteins during chemotherapy is an effective therapeutic strategy for overcoming the chemoresistance of NSCLC cells. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | SPRINGER | - |
dc.subject | STEM-CELLS | - |
dc.subject | MOLECULAR-MECHANISMS | - |
dc.subject | RESISTANCE | - |
dc.subject | CHEMOTHERAPY | - |
dc.subject | CONTRIBUTES | - |
dc.subject | HYALURONAN | - |
dc.subject | MARKERS | - |
dc.title | Self-targeted knockdown of CD44 improves cisplatin sensitivity of chemoresistant non-small cell lung cancer cells | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Yeonho | - |
dc.contributor.affiliatedAuthor | Kim, Hyun Koo | - |
dc.identifier.doi | 10.1007/s00280-018-3737-y | - |
dc.identifier.scopusid | 2-s2.0-85057991431 | - |
dc.identifier.wosid | 000460113100002 | - |
dc.identifier.bibliographicCitation | CANCER CHEMOTHERAPY AND PHARMACOLOGY, v.83, no.3, pp.399 - 410 | - |
dc.relation.isPartOf | CANCER CHEMOTHERAPY AND PHARMACOLOGY | - |
dc.citation.title | CANCER CHEMOTHERAPY AND PHARMACOLOGY | - |
dc.citation.volume | 83 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 399 | - |
dc.citation.endPage | 410 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | STEM-CELLS | - |
dc.subject.keywordPlus | MOLECULAR-MECHANISMS | - |
dc.subject.keywordPlus | RESISTANCE | - |
dc.subject.keywordPlus | CHEMOTHERAPY | - |
dc.subject.keywordPlus | CONTRIBUTES | - |
dc.subject.keywordPlus | HYALURONAN | - |
dc.subject.keywordPlus | MARKERS | - |
dc.subject.keywordAuthor | Chemoresistance | - |
dc.subject.keywordAuthor | Non-small cell lung carcinoma | - |
dc.subject.keywordAuthor | Hyaluronic acid-coated liposomes | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.